Navigation Links
At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
Date:4/15/2008

II clinical trial in diabetic patients in Canada. The study is a 26-week, double-blind, placebo-controlled, randomized study. Interim results are expected in late 2008 or early 2009. The screening of the first patient for this study was completed last week.

Leveraging the many years of accumulated knowledge and the experience it has gained in developing tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's disease (AD), Neurochem will prioritize and accelerate the development of a prodrug of tramiprosate (ALZHEMED(TM)), a new chemical entity (NCE), for the treatment of AD. A prodrug is a pharmaceutical substance which is administered in an inactive form and, once absorbed, is metabolized in vivo into its active form (in this case, tramiprosate). This NCE has potential patent protection until 2027.

Financial Update

Neurochem indicated that it expects to spend less in fiscal 2008 than in 2007, due in large part to the discontinuation of the European Phase III clinical trial for tramiprosate (ALZHEMED(TM)). The Company completed fiscal 2007 with approximately US$59 million cash on hand, enough to finance the current needs of Neurochem's pharmaceutical and branded nutraceutical activities. Management indicated that additional financing could be contemplated if required and that it can count on the continued support of Picchio Pharma, the Company's major shareholder

Board Members

Neurochem expresses its thanks and appreciation to Mr. Jean-Guy Desjardins, President and Chief Executive Officer of Centria Inc. who has served on the Board since 2004 and whose term comes to an end with the close of today's shareholders' meeting. At the same time the Company welcomes Ms. Helene Fortin to its Board. Ms. Helene Fortin is one of Quebec's leading chartered accountants, and has been a practicing partner since 1989, now with CGF CA - Chartered Accountants. Ms. Fortin is a member of the board of directors of a number of important Canadian com
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Otter Tail Corporation Holds 2008 Annual Meeting: Shareholders Elect Directors; Board Declares Quarterly Dividend
2. Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the Annual Meeting of the American Association for Cancer Research
3. Northwest Hospital & Medical Center Hosts Health & Wellness Pavilion At Second Annual King 5 Healthy Living Expo
4. European Society of Human Reproduction & Embryology 24th annual meeting
5. Media advisory - Neurochems Annual and Special Meeting of Shareholders April 15, 2008
6. Neurochem Annual and Special Meeting of shareholders
7. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
8. China Medical Technologies to Announce 4QFY2007 Financial Results, Declare Annual Cash Dividend and Provide FY2008 Annual Targets on June 12, 2008
9. HealthMEDX Hosts Annual User Group Conference
10. Abaxis to Present at the SunTrust Robinson Humphreys 37th Annual Institutional Unconference
11. Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Foundations ... proud to announce the start of its 41st national ... author Jane McGonigal, and former Congressman Patrick J. Kennedy ... Conference being held in San Diego, CA, March ... Coronado. The national conference brings together leading experts specializing ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 The Consumer Attorneys ... Skills for the New Attorney” seminar for attorneys who passed ... brings top trial attorneys in the Southern California area to ... Doctors on Liens was on hand, not ... to the doctors their clients will need to help in ...
(Date:3/30/2015)... March 30, 2015 KIND LED’s suite of ... light products in 2015. The excellent value and product features ... take the pole position in the race for the best ... the KIND LED suite of grow lights is the ... Photosynthetic Active Radiation (PAR) wavelengths that plants are most likely ...
(Date:3/30/2015)... Healtheminds, a start-up focusing on providing high ... easy to use and engaging online platform, is launching ... health related issues. The first in the series is ... other drugs. , Consumption and use of alcohol ... the toxic effects of excessive intake or drug overdoses, ...
(Date:3/30/2015)... 2015 Dr. Jeffrey Allred DDS, with his ... minute second opinion consultations for patients who need ... on dental second opinions show how small percentage of dentistry ... works. Only 6%” – says Dr. Allred. , “People ... fully trusting the dental care provider, for the simple fact ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 3Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2
... Cancer Center researchers have identified a new population of intestinal ... colorectal cancer. , This new stem cell population, reported March ... relatively quiescent (inactive) in contrast to the recent discovery ... marked by a protein, Lrig1, that may act as a ...
... Ill. -- The American Society for Gastrointestinal Endoscopy (ASGE) ... program specifically dedicated to promoting quality in endoscopy, in ... States. The ASGE Endoscopy Unit Recognition Program honors endoscopy ... assurance, endoscope reprocessing and CDC infection control guidelines. To ...
... News) -- Tourists over age 65 who visit malaria-infested regions are ... those ages 18 to 35, a new study says. The ... patients also found that the malaria death rate is particularly high ... of dying from malaria, an infection carried by mosquitoes, increased with ...
... with intensity modulated radiation therapy (IMRT) instead of standard ... acute or chronic toxicities, according to a study in ... official clinical practice journal of the American Society for ... determine the most effective breast cancer treatment that also ...
... 27 (HealthDay News) -- Women with ovarian cancer who ... have annual incomes of less than $35,000 are more ... Researchers found these racial and socioeconomic disparities in ... of surviving for five years after their cancer diagnosis. ...
... have identified genetic causes in nearly 1 in 5 patients ... Carolyn Jones, MD, PhD, of Loyola University Medical Center, ... of Cardiac Failure . First author is Neal Lakdawala, MD, ... on 264 patients with dilated cardiomyopathy and found that 17.4 ...
Cached Medicine News:Health News:Newly identified stem cells may hold clues to colon cancer 2Health News:ASGE recognizes 18 endoscopy units for quality 2Health News:Older Travelers at Much Higher Risk of Dying From Malaria 2Health News:IMRT reduces risk of side effects in breast cancer patients 2Health News:Black Women, Uninsured Get Worse Ovarian Cancer Care: Study 2Health News:Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure 2
(Date:3/30/2015)... Calif. , March 30, 2015  Cochlear ... has decided to leave Cochlear to join Valencia ... and friend, Jeff Greiner , who is ... Chief of Market Development and will be responsible ... of Valencia,s coin-sized neuromodulation ...
(Date:3/30/2015)...  Edison Nation Medical, the premier healthcare innovation ... innovations to assist seniors in staying mobile and ... 8-week search will be presented to major medical ... be submitted through a secure, confidential portal at ... The objective of the Senior Mobility ...
(Date:3/30/2015)... DURECT Corporation (Nasdaq: DRRX ) ... Phase 1 clinical trial of an oral formulation ... Regulator Program.  DUR-928 is an endogenous, small-molecule, new ... in metabolic diseases such as nonalcoholic fatty liver ... also play an important role in protecting against ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... LAKES, N.J., Jan. 4, 2011 BD (Becton, Dickinson and Company) ... announced today that it will present at the 29th Annual J. ... p.m. (ET). A live webcast of BD,s presentation ... and will be available for replay through Monday, January 17, ...
... (Nasdaq: ERES ), announced today that Dr. Joel ... Company,s Chief Financial Officer, are scheduled to present at the ... on January 13, 2011 in San Francisco, California. ... corporate website at http://www.ert.com . The webcast may also ...
Cached Medicine Technology:ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011 2
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
The 5524-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
The 9114-3.5 transducer is a versatile general imaging transducer. With multifrequencies, this transducer provides superb image quality and meets a multitude of imaging needs....
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: